PAHC

Phibro Animal Health Corporation

$34.64

0.09%
SectorHealthcareIndustryDrug Manufacturers - Specialty & GenericCountryUnited States

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers.

Source: Yahoo Finance
AI summary

Price & performance

1M-4.8%
3M-1.4%
YTD-4.2%
1Y-12.9%
52-week range—
Beta1.15
Full chart and returns against a benchmark

Q-Score

76/ 100

Quality against peers; 50 is the peer median.

Growth64
Risk64
Performance68
Valuation75
Profitability71
Leverage56
Sentiment55
Every score and metric

News sentiment

Open News

Latest results · FY 2026

Revenue$1.5B+17.1%
Net income$99.7M+106.6%
Net margin6.6%+2.8 pts
Historical fundamentals

Revenue exposure

42%of revenue from outside the US
United States58%
Latin America and Canada22%
EMEA12%
Regions, segments, customers and suppliers

Valuation

PAHCIndustryP/E13.6935.25P/S0.912.74EV/EBITDA7.9216.35P/B3.372.46PEG0.270.87
Dividend yield1.38%
Every valuation metric

Earnings

Feb 3next report
EPS estimate$0.76
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate